2-Amino-2,3-dimethylbutyramide

We are 2-Amino-2,3-dimethylbutyramide CAS:40963-14-2 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

CAS No: 40963-14-2
Product Name: 2-Amino-2,3-dimethylbutyramide
Other Name:
2-Amino-2,3-dimethylbutyramide
2,3-dimethyl-2-aminobutanamide
 
Density: 0.982g/cm3
Boiling Point: 242.7ºC at 760mmHg
Molecular Formula: C6H14N2O
Molecular Weight: 130.18800
Flash Point: 100.6ºC
Exact Mass: 130.11100
PSA: 69.11000
LogP: 1.24570
Index of Refraction: 1.469
 
Specification
Appearance: White Crystal
Assay: ≥99.0%
Loss on drying: ≤0.5%
 
Application
Intermediates of Imazamox CAS: 114311-32-9.
Intermediates of Imazaquin CAS: 81335-37-7.
Intermediates of Imazethapyr CAS: 81335-77-5.
Intermediates of Imazapyracid CAS: 81334-34-1.
Intermediates of Imazamethabenz-Methyl CAS: 81405-85-8.
Be used as pesticide intermediate. 2-Amino-2,3-dimethylbutylamide is an intermediate of the herbicides imazamic acid, imaza-nicotinic acid, imidazole-nicotinic acid, imidazoquinic acid, and imazamox.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.

2-Amino-2,3-dimethylbutyramide


Related News: We also have to consider the degree of concentration and which temperature allows a high quality of API to be manufactured efficiently.331759-58-1 We also have to consider the degree of concentration and which temperature allows a high quality of API to be manufactured efficiently.L-CYSTEINE HCL H2O CAS:7048-04-6 GlaxoSmithKline (GSK) is at the bottom of the top 20 list with the lowest percentage R&D spend/annual revenue at 12%.”3-Aminobenzotrifluoride CAS:98-16-8 At Day 35 following administration, a bone marrow assessment showed that FT819 persisted and continued to demonstrate tumor clearance, whereas primary CAR T cells, while persisting, were not able to control tumor growth.At Day 35 following administration, a bone marrow assessment showed that FT819 persisted and continued to demonstrate tumor clearance, whereas primary CAR T cells, while persisting, were not able to control tumor growth.

Related Products
Product Name
N-[4-(4-Fluorophenyl)-5-formyl-6-(1-methylethyl)-2-pyrimidinyl]-N-methyl-methanesulfonamide View Details
2-Hydroxy-5-methyl-3-nitropyridine View Details
2-Chloro-3-fluoro-5-nitropyridine View Details
1-Methoxy-2-propanol manufacturer 3-Piperazinobenzisothiazole Hydrochloride manufacturer 4-propan-2-yl-1,3-thiazole-2-carboxylic acid manufacturer 1,3-Diaminobenzene Sulfate manufacturer (3-(9H-Carbazol-9-yl)phenyl)boronic acid manufacturer